Several panelists on both sides of the vote in adolescents said they would give deference to FDA on this population in light of the agency’s past experience with extrapolating adult efficacy data. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
